Erratum: Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis (International Urology Nephrology (2003) vol. 35 (393-397) 10.1023/B:UROL.0000022846.83505.3f);Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis

International Urology and Nephrology

Volumn 35, Issue 3, 2003, Pages 393-397

  Samouilidou, Elisabeth C ^a   Grapsa, Eirini J ^b   Kakavas, Ioannis ^c   Lagouranis, Antonios ^b   Agrogiannis, Basilis ^d  

^a Biochemical Department   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

^c Ippokration Hospital Thessaloniki   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

4 hydroxyalkenals; C reactive protein; Hemodialysis; Malonaldehyde; Peritoneal dialysis; Total antioxidant capacity

Indexed keywords

C REACTIVE PROTEIN; HEPARIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPID; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; MALONALDEHYDE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL; AGE; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; HOSPITALIZATION; KIDNEY FUNCTION TEST; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RENAL DIALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 3042805321     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-007-9248-0     Document Type: Erratum

References (24)

1. Tetta C, Biasoli S, Schiavon R, Inguaggiato P, David S. An overview of hemodialysis and oxidative stress. Blood Purif 1999; 17: 118-126.
2. Fiorillo C, Oliviero C, Rizzuti G, Nediani C, Pacini A. Oxidative stress and antioxidant defenses in renal patients receiving regular hemodialysis. Clin Chem Lab Med 1998; 36: 149-153.
3. Morena M, Cristol JP, Canaud B. Why hemodialysis patients are in prooxidant state? What could be done to correct the pro/antioxidant imbalance? Blood Purif 2000; 18: 191-199.
4. Mimic-Oka J, Simic T, Djukanovic L, Reljic Z, Davicevic Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 1999; 51: 233-241.
5. Donica H. Evaluation of lipids peroxidation products vs. proinflammatory cytokines in hemodialyzed patients. Ren Fail 2001; 23: 231-238.
6. Jackson P, Loughrey C, Lightbody J, Mc Namee P, Young I. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-1138.
7. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 1992; 60: 56-59.
8. Daschner M, Lenhartz H, Bötticher D, Schaffer F, Wollschläger M, Leichsenring M. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney International 1996; 50: 1268-1272.
9. Docci D, Bilancioni R, Busocardi A, Baldati L, Capponcini C. Elevated levels of C-reactive protein in hemodialysis patients. Nephron 1990; 56: 364-367.
10. Nguyen-Koha T, Massy ZA, De Bandt JP, Kebede M. Oxidative stress in hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Tranplant 2001; 16: 335-340.
11. Mc Intryre C, Harper I, Mac Dougal IC, Ralne AEG, Williams A. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol 1997; 48: 371-374.
12. Spittle MA, Hoenich NA, Handelman GI, Hamel P, Levin NW. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney 2001; 38: 1408-1413.
13. Panichi V, Migliori M, De Pietro S, Taccola D. C-reactive protein as a marker for chronic inflammation in hemodialysis patients. Blood Purif 2000; 18: 183-190.
14. Kim SB, Yang WS, Min WK, Lee SK, Park JS. Reduced oxidative stress in hypoalbuminemic CAPD patients. Perit Dial Int 2000; 20: 290-294.
15. Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK. Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients. Perit Dial Int 1992; 12: 252-256.
16. Dasgupta A, Malhorta D, Levy H, Marcadis D, Blackwell W, Johnson D. Decreased total antioxidant capacity but normal lipid hydroperoxide concentrations in sera of critically ill patients. Life Sci 1997; 60: 335-340.
17. Haubitz M, Brunkhorst R, Wrenger E, Froese, Schulze E. Chronic induction of C-reactive protein by hemodialysis but not by peritoneal dialysis therapy. Perit Dial Int 1996; 16: 158-162.
18. Herzig K, Purdie DM, Chang W, Brown AM, Hawley CM. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2001; 12: 814-821.
19. Morrow DA, Ridker DM. C-reactive protein, inflammation and coronary risk. Med Clin North Am 2000; 84: 149-161.
20. Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med 1999; 17: 1019-1025.
21. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner. A novel method in measuring antioxidant capacity and its application to monitoring antioxidant status in premature neonates. Clin Sci 1993; 84: 407-412.
22. Descamps-Latscha B, Goldford B, Nguyen AT. Establishing the relationship between complement activation and stimulation of phagocyte oxitative metabolism in hemodialysed patients: a randomized prospective study. Nephron 1991; 59: 279-285.
23. Schnindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription not synthesis of IL-1 and TNF by complement. Kidney Int 1990; 37: 85-93.
24. Topey N, Mackenzy R, Jörres A, Coles GA, Davies M. Cytokine networks in continuous ambulatory peritonel dialysis patients: interactions of resident cells during inflammation in pentoneal cavity. Perit Dial Int 1993; 13(Suppl 2): 282-285.